This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, S.
Right arrow Articles by Pike, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, S.
Right arrow Articles by Pike, J. W.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, September 2006, p. 6469-6486, Vol. 26, No. 17
0270-7306/06/$08.00+0     doi:10.1128/MCB.00353-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Activation of Receptor Activator of NF-{kappa}B Ligand Gene Expression by 1,25-Dihydroxyvitamin D3 Is Mediated through Multiple Long-Range Enhancers{dagger}

Sungtae Kim, Miwa Yamazaki, Lee A. Zella, Nirupama K. Shevde, and J. Wesley Pike*

Department of Biochemistry, University of Wisconsin—Madison, Madison, Wisconsin 53706

Received 27 February 2006/ Returned for modification 4 May 2006/ Accepted 12 June 2006

RANKL is a tumor necrosis factor (TNF)-like factor secreted by mesenchymal cells, osteoblast derivatives, and T cells that is essential for osteoclastogenesis. In osteoblasts, RANKL expression is regulated by two major calcemic hormones, 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] and parathyroid hormone (PTH), as well as by several inflammatory/osteoclastogenic cytokines; the molecular mechanisms for this regulation are unclear. To identify such mechanisms, we screened a DNA microarray which tiled across the entire mouse RankL gene locus at a 50-bp resolution using chromatin immunoprecipitation (ChIP)-derived DNA precipitated with antibodies to the vitamin D receptor (VDR) and the retinoid X receptor (RXR). Five sites of dimer interaction were observed on the RankL gene centered at 16, 22, 60, 69, and 76 kb upstream of the TSS. These regions contained binding sites for not only VDR and RXR, but also the glucocorticoid receptor (GR). The most distant of these regions, termed the distal control region (RL-DCR), conferred both VDR-dependent 1,25(OH)2D3 and GR-dependent glucocorticoid (GC) responses. We mapped these activities to an unusual but functionally active vitamin D response element and to several potential GC response elements located over a more extensive region within the RL-DCR. An evolutionarily conserved region within the human RANKL gene contained a similar vitamin D response element and exhibited an equivalent behavior. Importantly, hormonal activation of the RankL gene was also associated with chromatin modification and RNA polymerase II recruitment. Our studies demonstrate that regulation of RankL gene expression by 1,25(OH)2D3 is complex and mediated by at least five distal regions, one of which contains a specific element capable of mediating direct transcriptional activation.


* Corresponding author. Mailing address: Department of Biochemistry, University of Wisconsin—Madison, 433 Babcock Dr., Madison, WI 53706. Phone: (608) 262-8229. Fax: (608) 263-7609. E-mail: pike{at}biochem.wisc.edu.

{dagger} Supplemental material for this article may be found at http://mcb.asm.org/.


Molecular and Cellular Biology, September 2006, p. 6469-6486, Vol. 26, No. 17
0270-7306/06/$08.00+0     doi:10.1128/MCB.00353-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Sundaram, K., Senn, J., Yuvaraj, S., Rao, D. S., Reddy, S. V. (2009). FGF-2 Stimulation of RANK Ligand Expression in Paget's Disease of Bone. Mol. Endocrinol. 23: 1445-1454 [Abstract] [Full Text]  
  • CARLBERG, C., SEUTER, S. (2009). A Genomic Perspective on Vitamin D Signaling. Anticancer Res 29: 3485-3493 [Abstract] [Full Text]  
  • Zhang, X., Dowd, D. R., Moore, M. C., Kranenburg, T. A., Meester-Smoor, M. A., Zwarthoff, E. C., MacDonald, P. N. (2009). Meningioma 1 Is Required for Appropriate Osteoblast Proliferation, Motility, Differentiation, and Function. J. Biol. Chem. 284: 18174-18183 [Abstract] [Full Text]  
  • Pike, J. W., Meyer, M. B., Martowicz, M. L. (2009). New Techniques in Transcription Research Extend Our Understanding of the Molecular Actions of the Vitamin D Hormone. IBMS BoneKEy 6: 169-180 [Abstract] [Full Text]  
  • Gerber, A. N., Masuno, K., Diamond, M. I. (2009). Discovery of selective glucocorticoid receptor modulators by multiplexed reporter screening. Proc. Natl. Acad. Sci. USA 106: 4929-4934 [Abstract] [Full Text]  
  • Mencej-Bedrac, S., Prezelj, J., Kocjan, T., Teskac, K., Ostanek, B., Smelcer, M., Marc, J. (2009). The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density. J Mol Endocrinol 42: 239-247 [Abstract] [Full Text]  
  • Bikle, D. (2009). Nonclassic Actions of Vitamin D. J. Clin. Endocrinol. Metab. 94: 26-34 [Abstract] [Full Text]  
  • Pan, Y. F., Wansa, K. D. S. A., Liu, M. H., Zhao, B., Hong, S. Z., Tan, P. Y., Lim, K. S., Bourque, G., Liu, E. T., Cheung, E. (2008). Regulation of Estrogen Receptor-mediated Long Range Transcription via Evolutionarily Conserved Distal Response Elements. J. Biol. Chem. 283: 32977-32988 [Abstract] [Full Text]  
  • White, J. H. (2008). Vitamin D Signaling, Infectious Diseases, and Regulation of Innate Immunity. Infect. Immun. 76: 3837-3843 [Full Text]  
  • Zella, L. A., Shevde, N. K., Hollis, B. W., Cooke, N. E., Pike, J. W. (2008). Vitamin D-Binding Protein Influences Total Circulating Levels of 1,25-Dihydroxyvitamin D3 but Does Not Directly Modulate the Bioactive Levels of the Hormone in Vivo. Endocrinology 149: 3656-3667 [Abstract] [Full Text]  
  • Nerenz, R. D., Martowicz, M. L., Pike, J. W. (2008). An Enhancer 20 Kilobases Upstream of the Human Receptor Activator of Nuclear Factor-{kappa}B Ligand Gene Mediates Dominant Activation by 1,25-Dihydroxyvitamin D3. Mol. Endocrinol. 22: 1044-1056 [Abstract] [Full Text]  
  • Galli, C., Zella, L. A., Fretz, J. A., Fu, Q., Pike, J. W., Weinstein, R. S., Manolagas, S. C., O'Brien, C. A. (2008). Targeted Deletion of a Distant Transcriptional Enhancer of the Receptor Activator of Nuclear Factor-{kappa}B Ligand Gene Reduces Bone Remodeling and Increases Bone Mass. Endocrinology 149: 146-153 [Abstract] [Full Text]  
  • Yuan, W., Pan, W., Kong, J., Zheng, W., Szeto, F. L., Wong, K. E., Cohen, R., Klopot, A., Zhang, Z., Li, Y. C. (2007). 1,25-Dihydroxyvitamin D3 Suppresses Renin Gene Transcription by Blocking the Activity of the Cyclic AMP Response Element in the Renin Gene Promoter. J. Biol. Chem. 282: 29821-29830 [Abstract] [Full Text]  
  • Ewing, A. K., Attner, M., Chakravarti, D. (2007). Novel Regulatory Role for Human Acf1 in Transcriptional Repression of Vitamin D3 Receptor-Regulated Genes. Mol. Endocrinol. 21: 1791-1806 [Abstract] [Full Text]  
  • Lazarenko, O. P., Rzonca, S. O., Hogue, W. R., Swain, F. L., Suva, L. J., Lecka-Czernik, B. (2007). Rosiglitazone Induces Decreases in Bone Mass and Strength that Are Reminiscent of Aged Bone. Endocrinology 148: 2669-2680 [Abstract] [Full Text]  
  • Kim, S., Yamazaki, M., Shevde, N. K., Pike, J. W. (2007). Transcriptional Control of Receptor Activator of Nuclear Factor-{kappa}B Ligand by the Protein Kinase A Activator Forskolin and the Transmembrane Glycoprotein 130-Activating Cytokine, Oncostatin M, Is Exerted through Multiple Distal Enhancers. Mol. Endocrinol. 21: 197-214 [Abstract] [Full Text]  
  • Fu, Q., Manolagas, S. C., O'Brien, C. A. (2006). Parathyroid Hormone Controls Receptor Activator of NF-{kappa}B Ligand Gene Expression via a Distant Transcriptional Enhancer.. Mol. Cell. Biol. 26: 6453-6468 [Abstract] [Full Text]